Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 7, 2021
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
Fri, June 4, 2021
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
Andrew Berens Maintained (AZN) at Buy with Increased Target to $64 on, Jun 4th, 2021
Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Increased Target from $63 to $64 on, Jun 4th, 2021.
Andrew has made no other calls on AZN in the last 4 months.
There are 3 other peers that have a rating on AZN. Out of the 3 peers that are also analyzing AZN, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, April 12th, 2021
These are the ratings of the 2 analyists that currently disagree with Andrew
- Peter Welford of "Jefferies" Upgraded from Hold to Strong Buy on, Tuesday, March 16th, 2021
- Michael Leuchten of "UBS" Upgraded from Hold to Strong Buy on, Thursday, February 25th, 2021
